SCHEMBL17080912

SCHEMBL17080912

CC(C)(C)OC(=O)N1CCC(c2cccc3sc(C(=O)O)cc23)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.46
KDM4E B2RXH2 3/20 0.45
MAPT P10636 1/20 0.45
THRB P10828 1/20 0.45
MMP13 P45452 1/20 0.44
ACKR3 P25106 1/20 0.43
HPGDS O60760 1/20 0.43
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
PKM P14618 1/20 0.42
HTT P42858 2/20 0.42
NAMPT P43490 1/20 0.41
HPGD P15428 2/20 0.41
HSD17B10 Q99714 2/20 0.41
USP2 O75604 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
SCN9A Q15858 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41
CRHBP P24387 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17080915 0.88 TP53 (0.50) GPR119KDM4EMAPTTHRBMMP13
SCHEMBL17080817 0.81 ACKR3 (0.47) GPR119MAPTACKR3ALDH1A1
SCHEMBL17080911 0.80 GPR119 (0.46) GPR119KDM4EMAPTTHRBHPGDS
SCHEMBL19297245 0.79 MEN1 (0.50) GPR119KDM4EMAPTTHRBHPGDS
SCHEMBL19284564 0.77 P2RY14 (0.51) GPR119KDM4EMAPTTHRBHPGDS
SCHEMBL23443529 0.77 GPR119 (0.53) GPR119KDM4EMAPTTHRBHPGDS
SCHEMBL30368880 0.77 GPR119 (0.53) GPR119KDM4EMAPTTHRBHPGDS
SCHEMBL6606633 0.77 GPR119 (0.53) GPR119KDM4EMAPTTHRBHPGDS
SCHEMBL25172126 0.77 MAPT (0.49) GPR119KDM4EMAPTTHRBMEN1
SCHEMBL19284733 0.76 GPR119 (0.50) GPR119KDM4EMAPTTHRBPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3115361-B1 HETEROCYCLIC COMPOUNDS, AND PREPARATION METHOD AND USE THEREOF SHANGHAI INST MATERIA MEDICA CAS (CN) 2019-10-23 EP disclosed
US-10174011-B2 Heterocyclic compounds, process for preparation of the same and use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2019-01-08 US disclosed
US-20170158680-A1 HETEROCYCLIC COMPOUNDS, PROCESS FOR PREPARATION OF THE SAME AND USE THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2017-06-08 US disclosed
US-20170158680-A1 HETEROCYCLIC COMPOUNDS, PROCESS FOR PREPARATION OF THE SAME AND USE THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2017-06-08 US disclosed
EP-3115361-A1 HETEROCYCLIC COMPOUNDS, AND PREPARATION METHOD AND USE THEREOF Shanghai Institute Of Materia Medica Chinese Academy of Sciences (CN) 2017-01-11 EP disclosed
WO-2015131856-A1 HETEROCYCLIC COMPOUNDS, AND PREPARATION METHOD AND USE THEREOF 中国科学院上海药物研究所 2015-09-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10174011-B2 Heterocyclic compounds, process for preparation of the same and use thereof CYP11B2, CYP11B1, ADCYAP1R1 GPR119 1108/4885KDM4E 2810/4885MAPT 280/4885
US-20170158680-A1 HETEROCYCLIC COMPOUNDS, PROCESS FOR PREPARATION OF THE SAME AND USE THEREOF CYP11B2, CYP11B1, ADCYAP1R1 GPR119 1108/4885KDM4E 2810/4885MAPT 280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.